OLRATAN TRIO 6.25 TABLET

Product Description

OLRATAN TRIO 6.25 TABLET is a powerful combination antihypertensive medication expertly formulated with Olmesartan Medoxomil 20 mg, Cilnidipine 10 mg, and Chlorthalidone 6.25 mg. Designed to deliver effective blood pressure control, this triple-action tablet targets hypertension through multiple mechanismsblocking angiotensin receptors, calcium channels, and promoting diuresis for superior cardiovascular protection.

This high-efficacy formulation is ideal for pharmaceutical distributors, hospital chains, retail pharmacies, and bulk buyers seeking a trusted solution to manage essential hypertension and prevent complications like stroke, heart failure, and renal impairment.

Key Benefits:

• Combines three potent antihypertensive agents for comprehensive blood pressure management

• Enhances vascular relaxation, reduces fluid retention, and lowers peripheral resistance

• Improves patient compliance by simplifying therapy with a single-tablet regimen

• Manufactured under strict GMP guidelines ensuring quality and safety

Usage:

• Recommended for patients with essential hypertension requiring combination therapy

• Effective in reducing risks associated with cardiovascular and renal diseases

• Suitable for long-term management in both outpatient and hospital settings

Why Choose OLRATAN TRIO 6.25?

• Superior therapeutic efficacy with Olmesartan, Cilnidipine, and Chlorthalidone combo

• Competitive pricing for bulk pharmaceutical procurement

• Reliable stock availability for timely distribution